Ulcer healing · ulceration and other skin changes caused by nerve damage in leprosy
2 findings from 1 review
Adverse events associated with treatment · ulceration and other skin changes caused by nerve damage in leprosy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Secondary outcome: quality of life · ulceration and other skin changes caused by nerve damage in leprosy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Secondary outcome: acceptability of treatment · ulceration and other skin changes caused by nerve damage in leprosy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Costs · ulceration and other skin changes caused by nerve damage in leprosy
1 finding from 1 review
Changes in intensity of pain (VAS 0 to 10) tested through air blast stimuli · Patients aged above 12 years with self-reported tooth hypersensitivity confirmed on clinical evaluation
It is very uncertain whether in-office laser therapy (all types combined) changes changes in intensity of pain (VAS 0 to 10) tested through air blast… compared with placebo (placebo laser or placebo agent) or no treatment (very low certainty).
3 findings from 1 review
Adverse events · Patients aged above 12 years with self-reported tooth hypersensitivity confirmed on clinical evaluation
2 findings from 1 review
Changes in intensity of pain (VAS 0 to 10) tested through tactile stimuli · Patients aged above 12 years with self-reported tooth hypersensitivity confirmed on clinical evaluation
It is very uncertain whether in-office laser therapy (all types combined) changes changes in intensity of pain (VAS 0 to 10) tested through tactile… compared with placebo (placebo laser or placebo agent) or no treatment (very low certainty).
3 findings from 1 review
Patient-reported quality of life · Patients aged above 12 years with self-reported tooth hypersensitivity confirmed on clinical evaluation
The review found no eligible studies for this question.
1 finding from 1 review
Participant‐reported pain relief of 30% or greater · patients with adhesive capsulitis (frozen shoulder)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain intensity (0‐10cm visual analogue scale) · patients with adhesive capsulitis (frozen shoulder)
1 finding from 1 review
Function (change from baseline) Shoulder Disabilty Questionnaire 0‐100 (lower scores = better function) · patients with adhesive capsulitis (frozen shoulder)
1 finding from 1 review
Global assessment of treatment success · patients with adhesive capsulitis (frozen shoulder)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Active shoulder abduction · patients with adhesive capsulitis (frozen shoulder)
1 finding from 1 review
Quality of life · patients with adhesive capsulitis (frozen shoulder)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · patients with adhesive capsulitis (frozen shoulder)
1 finding from 1 review
Outcomes* · preterm infants with type 1 ROP
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Structural outcome ‐ retinal detachment · preterm infants with type 1 ROP
Anti‐vascular endothelial growth factor therapy combined with… may leads to lower structural outcome ‐ retinal detachment (unit of analysis: eyes) compared with laser/cryotherapy (low certainty).
1 finding from 1 review
Local adverse effects ‐ perioperative retinal haemorrhages (unit of analysis: eyes) · preterm infants with type 1 ROP
It is very uncertain whether anti‐vascular endothelial growth factor therapy combined with… changes local adverse effects ‐ perioperative retinal haemorrhages (unit of… compared with laser/cryotherapy (very low certainty).
1 finding from 1 review
Recurrence of ROP by 55 weeks' PMA · preterm infants with type 1 ROP
Anti‐vascular endothelial growth factor therapy combined with… may leads to lower recurrence of ROP by 55 weeks' postmenstrual age compared with laser/cryotherapy (low certainty).
1 finding from 1 review